InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Klima Thomas J, Directeur Commercial. Officer active across 1 company, notably bluebird bio, Inc.. Cumulatively, 18 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €42k. History available since 1 June 2021. The latest transaction was disclosed on 3 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
500 shares@ US$3.91940.1% of flowCommon StockSEC:0001562180-25-002089:0
122 shares@ US$7.39250.1% of flowCommon StockSEC:0001562180-25-000953:0
50,000 shares0Common StockSEC:0001562180-24-007125:0
3,834 shares@ US$0.97190.3% of flowCommon StockSEC:0001562180-24-004633:0
4,573 shares@ US$1.52760.5% of flowCommon StockSEC:0001562180-24-002305:0
2,714 shares@ US$0.90250.2% of flowCommon StockSEC:0001562180-24-001097:0
922 shares@ US$3.78860.2% of flowCommon StockSEC:0001562180-23-006737:0
4,130 shares@ US$3.4991.0% of flowCommon StockSEC:0001562180-23-004877:0
55,000 shares0Common StockSEC:0001562180-23-002405:0
2,260 shares@ US$6.381.0% of flowCommon StockSEC:0001562180-23-000905:0
11,000 shares0Common StockSEC:0001562180-22-006518:0
3,753 shares@ US$3.07360.8% of flowCommon StockSEC:0001562180-22-004874:0
25,000 shares0Common StockSEC:0001562180-22-001084:0
25,000 shares0Common StockSEC:0001562180-22-001084
50,192 shares0Common StockSEC:0001628280-21-023464:0
50,192 shares0Common StockSEC:0001628280-21-023464
25,000 shares@ US$31.1149.6% of flowCommon StockSEC:0001562180-21-003923
25,000 shares@ US$31.1149.6% of flowCommon StockSEC:0001562180-21-003923:0
18 of 18 declarations
About Klima Thomas J
Thomas J. Klima is the Chief Commercial Officer at bluebird bio, Inc. He is responsible for the company's commercial strategy and business development. His experience in the biopharmaceutical industry enables him to lead initiatives aimed at increasing the visibility and reach of bluebird bio's products. He is committed to supporting the company's mission in innovation and healthcare.
